£30m initiative will support early-stage antimicrobial development
Drug Discovery World
OCTOBER 19, 2023
A partnership has been set up to promote the development of new treatments to tackle the global threat of antimicrobial resistance (AMR). Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 ($36) million initiative supporting early-stage innovation against AMR.
Let's personalize your content